Androgen therapy and atherosclerotic cardiovascular disease.
- Publication Type:
- Journal Article
- Citation:
- Vasc Health Risk Manag, 2008, 4 (1), pp. 11 - 21
- Issue Date:
- 2008
Closed Access
| Filename | Description | Size | |||
|---|---|---|---|---|---|
 | 2010001849OK.pdf | 386.01 kB |
Copyright Clearance Process
- Recently Added
- In Progress
- Closed Access
This item is closed access and not available.
Cardiovascular disease (CVD) remains the leading cause of death in Western society today. There is a striking gender difference in CVD with men predisposed to earlier onset and more severe disease. Following the recent reevaluation and ongoing debate regarding the estrogen protection hypothesis, and given that androgen use and abuse is increasing in our society, the alternate view that androgens may promote CVD in men is assuming increasing importance. Whether androgens adversely affect CVD in either men or women remains a contentious issue within both the cardiovascular and endocrinological fraternities. This review draws from basic science, animal and clinical studies to outline our current understanding regarding androgen effects on atherosclerosis, the major CVD, and asks where future directions of atherosclerosis-related androgen research may lie.
Please use this identifier to cite or link to this item: